These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 20882002

  • 21. Comprehensive antigenic map of a cleaved soluble HIV-1 envelope trimer.
    Derking R, Ozorowski G, Sliepen K, Yasmeen A, Cupo A, Torres JL, Julien JP, Lee JH, van Montfort T, de Taeye SW, Connors M, Burton DR, Wilson IA, Klasse PJ, Ward AB, Moore JP, Sanders RW.
    PLoS Pathog; 2015 Mar; 11(3):e1004767. PubMed ID: 25807248
    [Abstract] [Full Text] [Related]

  • 22. Stabilization of the V2 loop improves the presentation of V2 loop-associated broadly neutralizing antibody epitopes on HIV-1 envelope trimers.
    de Taeye SW, Go EP, Sliepen K, de la Peña AT, Badal K, Medina-Ramírez M, Lee WH, Desaire H, Wilson IA, Moore JP, Ward AB, Sanders RW.
    J Biol Chem; 2019 Apr 05; 294(14):5616-5631. PubMed ID: 30728245
    [Abstract] [Full Text] [Related]

  • 23. The Neutralizing Antibody Response to the HIV-1 Env Protein.
    Moore PL.
    Curr HIV Res; 2018 Apr 05; 16(1):21-28. PubMed ID: 29173180
    [Abstract] [Full Text] [Related]

  • 24. Isolation and characterization of a novel neutralizing antibody targeting the CD4-binding site of HIV-1 gp120.
    Qiao Y, Man L, Qiu Z, Yang L, Sun Y, He Y.
    Antiviral Res; 2016 Aug 05; 132():252-61. PubMed ID: 27387828
    [Abstract] [Full Text] [Related]

  • 25. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
    Hu JK, Crampton JC, Cupo A, Ketas T, van Gils MJ, Sliepen K, de Taeye SW, Sok D, Ozorowski G, Deresa I, Stanfield R, Ward AB, Burton DR, Klasse PJ, Sanders RW, Moore JP, Crotty S.
    J Virol; 2015 Oct 05; 89(20):10383-98. PubMed ID: 26246566
    [Abstract] [Full Text] [Related]

  • 26. Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens.
    Hessell AJ, Malherbe DC, Pissani F, McBurney S, Krebs SJ, Gomes M, Pandey S, Sutton WF, Burwitz BJ, Gray M, Robins H, Park BS, Sacha JB, LaBranche CC, Fuller DH, Montefiori DC, Stamatatos L, Sather DN, Haigwood NL.
    J Immunol; 2016 Apr 01; 196(7):3064-78. PubMed ID: 26944928
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Envelope proteins of two HIV-1 clades induced different epitope-specific antibody response.
    Shrivastava T, Samal S, Tyagi AK, Goswami S, Kumar N, Ozorowski G, Ward AB, Chakrabarti BK.
    Vaccine; 2018 Mar 14; 36(12):1627-1636. PubMed ID: 29429810
    [Abstract] [Full Text] [Related]

  • 30. HIV Broadly Neutralizing Antibodies: VRC01 and Beyond.
    Wu X.
    Adv Exp Med Biol; 2018 Mar 14; 1075():53-72. PubMed ID: 30030789
    [Abstract] [Full Text] [Related]

  • 31. Introduction of exogenous epitopes in the variable regions of the human immunodeficiency virus type 1 envelope glycoprotein: effect on viral infectivity and the neutralization phenotype.
    Wallace A, Stamatatos L.
    J Virol; 2009 Aug 14; 83(16):7883-93. PubMed ID: 19494007
    [Abstract] [Full Text] [Related]

  • 32. Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach.
    Martinez-Murillo P, Tran K, Guenaga J, Lindgren G, Àdori M, Feng Y, Phad GE, Vázquez Bernat N, Bale S, Ingale J, Dubrovskaya V, O'Dell S, Pramanik L, Spångberg M, Corcoran M, Loré K, Mascola JR, Wyatt RT, Karlsson Hedestam GB.
    Immunity; 2017 May 16; 46(5):804-817.e7. PubMed ID: 28514687
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer.
    Zhang P, Gorman J, Geng H, Liu Q, Lin Y, Tsybovsky Y, Go EP, Dey B, Andine T, Kwon A, Patel M, Gururani D, Uddin F, Guzzo C, Cimbro R, Miao H, McKee K, Chuang GY, Martin L, Sironi F, Malnati MS, Desaire H, Berger EA, Mascola JR, Dolan MA, Kwong PD, Lusso P.
    Cell Host Microbe; 2018 Jun 13; 23(6):832-844.e6. PubMed ID: 29902444
    [Abstract] [Full Text] [Related]

  • 36. The Effects of Framework Mutations at the Variable Domain Interface on Antibody Affinity Maturation in an HIV-1 Broadly Neutralizing Antibody Lineage.
    Zhou JO, Zaidi HA, Ton T, Fera D.
    Front Immunol; 2020 Jun 13; 11():1529. PubMed ID: 32765530
    [Abstract] [Full Text] [Related]

  • 37. Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex.
    Gift SK, Leaman DP, Zhang L, Kim AS, Zwick MB.
    J Virol; 2017 Dec 15; 91(24):. PubMed ID: 28978711
    [Abstract] [Full Text] [Related]

  • 38. A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies.
    Davis-Gardner ME, Alfant B, Weber JA, Gardner MR, Farzan M.
    mBio; 2020 Jan 14; 11(1):. PubMed ID: 31937648
    [Abstract] [Full Text] [Related]

  • 39. Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers In Vitro.
    Ozorowski G, Cupo A, Golabek M, LoPiccolo M, Ketas TA, Cavallary M, Cottrell CA, Klasse PJ, Ward AB, Moore JP.
    J Virol; 2018 Jul 01; 92(13):. PubMed ID: 29669838
    [Abstract] [Full Text] [Related]

  • 40. Alterations in the immunogenic properties of soluble trimeric human immunodeficiency virus type 1 envelope proteins induced by deletion or heterologous substitutions of the V1 loop.
    Ching L, Stamatatos L.
    J Virol; 2010 Oct 01; 84(19):9932-46. PubMed ID: 20660181
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.